Analyst Ratings for BioMarin Pharmaceutical Inc. (BMRN)
BMRN Rating Summary
BMRN Price Target Summary
- Highest: $124.00 (Morgan Stanley)
- Lowest: $60.00 (H.C. Wainwright)
- Average: $89.96
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$89.96 (+38.7%)
* Over Last 12-Mos
Rating Score: 7.1 / 10
Percentile Rank: 75%
Rating Score: 7.1 / 10
Percentile Rank: 75%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/18/2026 | BMO Capital | David Lebowitz | New Coverage | Outperform (N/A) |
98.00 (N/A) |
66.64 (64.84) |
-2.7% | Details |
| 5/20/2026 | JPMorgan | Jessica Fye | New Coverage | Overweight (N/A) |
80.00 (N/A) |
49.67 (64.84) |
30.54% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
